CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 8

Industry reads hand-picked by our editors

Jun 23, 2025

The New York Times
People With Severe Diabetes Are Cured in Small Trial of New Drug
Science News
Always ‘one atom away’: The long, rocky journey to an HIV prevention breakthrough
FirstWord Pharma
Otsuka signs $670M deal with Harbour for BCMAxCD3 bispecific

Jun 20, 2025

The New York Times
Why a Vaccine Expert Left the C.D.C.: ‘Americans Are Going to Die’
Nature
AI slashes time to produce gold-standard medical reviews — but sceptics urge caution
BioCentury
Amarin, Merck alum Karim Mikhail emerges as possible head of FDA’s CDER

Jun 18, 2025

The Wall Street Journal
Generic Drugmakers Resist Trump’s Calls for More U.S. Manufacturing
KFF Health News
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity
Reuters
US Senate Democrats demand Kennedy explain canceling bird flu vaccine contract

Jun 17, 2025

ProPublica
Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs
The Washington Post
CDC virus expert resigns after RFK Jr.’s purge of vaccine advisers
Nature
Judge rules against NIH grant cuts — and calls them discriminatory

Jun 16, 2025

Fierce Biotech
The trouble with TIGITs: How ‘overenthusiasm’ led to Big Pharma’s risky $6B gamble
Axios
NIH chief sidesteps controversy while other officials court it
NPR
The doctor said ‘be happy.’ Music therapy can help cancer patients do that
Bloomberg
China’s Biotech Moment Ignites a 60% Stock Rally That Beats AI

Jun 13, 2025

ProPublica
Shattered Science: The Research Lost as Trump Targets NIH Funding
Axios
RFK Jr. blows up America’s vaccine policy
The Wall Street Journal
Senators Propose Ban on Drug Advertising to Consumers

Jun 12, 2025

BioCentury
Makary, Prasad balance vows to speed reviews with industry criticism
Bloomberg
Lilly Pacts Prohibit Telehealth Sales of Copycat Zepbound
Nature
How to keep weight off after obesity drugs

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by 10x Genomics
Infographic
Accelerate clinical trials: Break silos, reduce delays Custom content for WCG
Survey Report
Data Science Drives 78% Growth in Drug Discovery by 2028 Custom content for Qiagen

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Built for the Storm: Why Prepared Systems Win in Pharma Webinar - on demand • Provided by Phase2
Peptides Under Pressure: Analytical Challenges in a High-Stakes Market Webinar - on demand • Provided by Solvias

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.